Hemsyl Cvp Tablet is a combination pharmaceutical formulation containing Ethamsylate (500 mg), Menadione (20 mcg), Citrus Bioflavonoid (150 mg), and Tribasic Calcium Phosphate (144 mg). This medication is primarily indicated for the management and prevention of bleeding disorders, particularly in cases of capillary fragility and hemorrhagic conditions. Ethamsylate acts as a hemostatic agent by promoting platelet aggregation and improving capillary resistance, thereby reducing bleeding time. Menadione, a synthetic form of vitamin K, plays a crucial role in the synthesis of clotting factors II, VII, IX, and X, essential for effective blood coagulation. Citrus Bioflavonoids contribute antioxidant properties and enhance vascular integrity by strengthening capillary walls and reducing permeability. Tribasic Calcium Phosphate serves as a calcium supplement, supporting bone health and aiding in various physiological functions. Hemsyl Cvp Tablet is utilized in clinical scenarios such as menorrhagia, postoperative bleeding, and capillary hemorrhages. The combination of these active ingredients offers a synergistic effect in controlling bleeding episodes and promoting vascular health. It is recommended to use this medication under medical supervision, considering contraindications such as hypersensitivity to any component and coagulation disorders. Dosage and duration should be tailored according to the patient’s clinical condition and response to therapy.